Skip to content
APOL15

Drawing based on the description in the official product monograph. No photo yet.

“15 mg: Hard gelatin capsules with green opaque body and pink opaque cap. Imprinted "APO L15" in APO-LANSOPRAZOLE (Lansoprazole) Page 10 of 94 white ink”

APO L15 pill

Pill with imprint APO L15 is green & pink, capsule and has been identified as Lansoprazole 15 mg. It is used for acid reflux (GERD), ulcers and stomach ulcers. It is supplied by Apotex Inc.

Sold in Canada

Lansoprazole 15 mg

Brand
Apo-Lansoprazole
Imprint
APO L15
Strength
15 mg
Used for
Acid reflux (GERD), ulcers and stomach ulcers
Color
Green, Pink
Shape
Capsule / oblong
Form
Capsule (delayed-release)
Manufacturer
Apotex Inc
Drug class
Acid reducer (proton pump inhibitor)
Sold in
Canada
DIN
02293811

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lansoprazole pills and guides

What is Lansoprazole used for?

Lansoprazole is used for acid reflux (GERD), ulcers, stomach ulcers and H. pylori infection.

Medicine type
Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label

Treatment of Active Duodenal Ulcer

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer.

Eradication of H. pylori to Reduce the Risk of Duodenal Ulcer Recurrence

Triple Therapy: Lansoprazole delayed-release orally disintegrating tablets /amoxicillin/clarithromycin

Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Please refer to the full prescribing information for amoxicillin and clarithromycin.

Dual Therapy: Lansoprazole delayed-release orally disintegrating tablets/amoxicillin

Lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual therapy is indicated in adults for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected (see the clarithromycin prescribing information, Microbiology section). Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Please refer to the full prescribing information for amoxicillin.

Maintenance of Healed Duodenal Ulcers

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of duodenal ulcers. Controlled studies do not extend beyond 12 months.

Treatment of Active Benign Gastric Ulcer

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (up to eight weeks) for healing and symptom relief of active benign gastric ulcer.

Healing of NSAID-Associated Gastric Ulcer

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the treatment of NSAID-associated gastric ulcer in patients who continue NSAID use. Controlled studies did not extend beyond eight weeks.

Risk Reduction of NSAID-Associated Gastric Ulcer

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for reducing the risk of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID. Controlled studies did not extend beyond 12 weeks.

Treatment of Symptomatic Gastroesophageal Reflux Disease (GERD)

Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for the treatment of heartburn and other symptoms associated with GERD.

Treatment of Erosive Esophagitis (EE)

Lansoprazole delayed-release orally disintegrating tablets are indicated for short-term treatment in adults and pediatric patients 12 to 17 years of age (up to eight weeks) and pediatric patients one to 11 years of age (up to 12 weeks) for healing and symptom relief of all grades of EE. For adults who do not heal with lansoprazole delayed-release orally disintegrating tablets for eight weeks (5 to 10%), it may be helpful to give an additional eight weeks of treatment. If there is a recurrence of erosive esophagitis an additional eight week course of lansoprazole delayed-release orally disintegrating tablets may be considered.

Maintenance of Healing of EE

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults to maintain healing of EE. Controlled studies did not extend beyond 12 months.

Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (ZES)

Lansoprazole delayed-release orally disintegrating tablets are indicated in adults for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows APO L15. The parts can be split between the two sides, so turn the pill over and check both.
  • It is green & pink, capsule.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Apo-Lansoprazole by Apotex Inc.

In Canada: prescription only.

Ingredients

Active: Lansoprazole

Other pills with imprint APO L15

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lansoprazole pills